Innovent Biologics
Qinwei Zhou currently serves as Chief Operating Officer at Innovent Biologics, Inc. since June 2016. Prior to this role, Qinwei Zhou held the position of Vice President at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, from June 1994 to June 2016. Qinwei Zhou is an alumnus of Fudan University.
This person is not in any teams
This person is not in any offices